Drug Shortage Report for TRANEXAMIC ACID INJECTION BP
| Report ID | 184263 |
| Drug Identification Number | 02246365 |
| Brand name | TRANEXAMIC ACID INJECTION BP |
| Common or Proper name | TRANEXAMIC ACID INJECTION BP |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | TRANEXAMIC ACID |
| Strength(s) | 100MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 10ML |
| ATC code | B02AA |
| ATC description | ANTIFIBRINOLYTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-02-08 |
| Estimated end date | 2023-02-24 |
| Actual end date | 2023-03-03 |
| Shortage status | Resolved |
| Updated date | 2023-03-04 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2023-03-04 | English | Compare |
| v5 | 2023-03-03 | French | Compare |
| v4 | 2023-03-03 | English | Compare |
| v3 | 2023-02-09 | French | Compare |
| v2 | 2023-02-09 | English | Compare |
| v1 | 2023-02-09 | English | Compare |
Showing 1 to 6 of 6